Impath (laboratories and cancer-testing units) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Impath (laboratories and cancer-testing units) General Information

Description

Operator of cancer testing laboratories. The company owns and operates cancer testing units and laboratories and offers experiment and research services.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • United States
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Sanofi Genzyme
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impath (laboratories and cancer-testing units) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Impath (laboratories and cancer-testing units)‘s full profile, request access.

Request a free trial

Impath (laboratories and cancer-testing units) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Impath (laboratories and cancer-testing units)‘s full profile, request access.

Request a free trial

Impath (laboratories and cancer-testing units) FAQs

  • Where is Impath (laboratories and cancer-testing units) headquartered?

    Impath (laboratories and cancer-testing units) is headquartered in .

  • What industry is Impath (laboratories and cancer-testing units) in?

    Impath (laboratories and cancer-testing units)’s primary industry is Laboratory Services (Healthcare).

  • Is Impath (laboratories and cancer-testing units) a private or public company?

    Impath (laboratories and cancer-testing units) is a Private company.

  • What is the current valuation of Impath (laboratories and cancer-testing units)?

    The current valuation of Impath (laboratories and cancer-testing units) is .

  • What is Impath (laboratories and cancer-testing units)’s current revenue?

    The current revenue for Impath (laboratories and cancer-testing units) is .

  • Who are Impath (laboratories and cancer-testing units)’s investors?

    Impath has invested in Impath (laboratories and cancer-testing units).

  • When was Impath (laboratories and cancer-testing units) acquired?

    Impath (laboratories and cancer-testing units) was acquired on 03-May-2004.

  • Who acquired Impath (laboratories and cancer-testing units)?

    Impath (laboratories and cancer-testing units) was acquired by Sanofi Genzyme.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »